Running title : Innate immune sensing of SARS-CoV-2 in macrophages 5 6
暂无分享,去创建一个
Sanjay Tyagi | E. Mühlberger | H. Akiyama | S. Gummuluru | Judith Olejnik | Ellen L Suder | Y. Bushkin | Ellen L. Suder | S. Jalloh | Annuurun Nisa | J. Berrigan | Maohua Lei | Sallieu Jalloh
[1] Vivek V. Thacker,et al. The cGAS–STING pathway drives type I IFN immunopathology in COVID-19 , 2022, Nature.
[2] Benjamin J. Polacco,et al. Evolution of enhanced innate immune evasion by SARS-CoV-2 , 2021, Nature.
[3] Xiaobo Zhou,et al. Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2 , 2021, Angiogenesis.
[4] H. Gendelman,et al. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions , 2021, Frontiers in Immunology.
[5] J. Lieberman,et al. Viral replication in human macrophages enhances an inflammatory cascade and interferon driven chronic COVID-19 in humanized mice. , 2021, bioRxiv : the preprint server for biology.
[6] A. Telenti,et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies , 2021, Nature.
[7] E. Shin,et al. Type I and III interferon responses in SARS-CoV-2 infection , 2021, Experimental & Molecular Medicine.
[8] Timothy L. Tickle,et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.
[9] R. Somasundaram,et al. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity , 2021, Infection.
[10] J. Rehwinkel,et al. The RNA sensor MDA5 detects SARS-CoV-2 infection , 2021, Scientific Reports.
[11] D. Neuberg,et al. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike , 2021, bioRxiv.
[12] D. Olive,et al. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis , 2021, The Journal of Infectious Diseases.
[13] M. Liao,et al. Rapid detection of SARS-CoV-2, replicating or non-replicating, using RT-PCR , 2021, International Journal of Infectious Diseases.
[14] Larissa B. Thackray,et al. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein , 2021, Cell.
[15] Helio T. Navarro,et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia , 2020, Nature.
[16] Cameron R. Wolfe,et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 , 2020, The New England journal of medicine.
[17] Z. Yin,et al. Controlling Cytokine Storm Is Vital in COVID-19 , 2020, Frontiers in Immunology.
[18] T. Kohlsdorf,et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients , 2020, The Journal of experimental medicine.
[19] V. Thiel,et al. Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.
[20] S. Neelamegham,et al. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration , 2020, eLife.
[21] Keith Sigel,et al. An inflammatory cytokine signature predicts COVID-19 severity and survival , 2020, Nature Medicine.
[22] E. Shin,et al. The type I interferon response in COVID-19: implications for treatment , 2020, Nature Reviews Immunology.
[23] K. Tashima,et al. Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience , 2020, Open forum infectious diseases.
[24] K. Zwirglmaier,et al. Rapid detection of SARS-CoV-2 by pulse-controlled amplification (PCA) , 2020, Journal of Virological Methods.
[25] S. Nisole,et al. Interplay between SARS-CoV-2 and the type I interferon response , 2020, PLoS pathogens.
[26] Guanqun Liu,et al. Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity. , 2020, Immunity.
[27] H. Akiyama,et al. HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages , 2020, Viruses.
[28] Jessie Huang,et al. SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response , 2020, bioRxiv.
[29] M. Gale,et al. Spatiotemporal dynamics of innate immune signaling via RIG-I–like receptors , 2020, Proceedings of the National Academy of Sciences.
[30] W. Xu,et al. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin , 2020, Signal Transduction and Targeted Therapy.
[31] L. Dodd,et al. Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.
[32] X. Xie,et al. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells , 2020, Cell.
[33] M. V. van Breemen,et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability , 2020, Science.
[34] I. Amit,et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.
[35] I. Amit,et al. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients , 2020, Cell.
[36] Jie Dong,et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.
[37] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[38] M. Hoffmann,et al. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.
[39] Fabian J Theis,et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes , 2020, Nature Medicine.
[40] M. Diamond,et al. TMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytes , 2020, bioRxiv.
[41] Carl H. June,et al. Cytokine release syndrome in severe COVID-19 , 2020, Science.
[42] M. Netea,et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.
[43] P. Loke,et al. Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties , 2020, Science Immunology.
[44] Hongyang Wang,et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing , 2020, Cell Discovery.
[45] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[46] M. Müller,et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform , 2020, Nature.
[47] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[48] S. Hur,et al. Regulation of cGAS- and RLR-mediated immunity to nucleic acids , 2019, Nature Immunology.
[49] J. Martinez-Picado,et al. Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry , 2019, Nature Microbiology.
[50] A. Belkina,et al. HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction , 2018, Nature Communications.
[51] Simon C Watkins,et al. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon , 2017, Journal of Virology.
[52] Heung Kyu Lee,et al. Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection , 2017, Front. Immunol..
[53] R. Swanstrom,et al. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells , 2017, Journal of Virology.
[54] A. Feizpour,et al. Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated. , 2016, Virology.
[55] H. Lipton,et al. Double-Stranded RNA Is Detected by Immunofluorescence Analysis in RNA and DNA Virus Infections, Including Those by Negative-Stranded RNA Viruses , 2015, Journal of Virology.
[56] H. Akiyama,et al. CD169-dependent cell-associated HIV-1 transmission: a driver of virus dissemination. , 2014, The Journal of infectious diseases.
[57] H. Akiyama,et al. Virus Particle Release from Glycosphingolipid-Enriched Microdomains Is Essential for Dendritic Cell-Mediated Capture and Transfer of HIV-1 and Henipavirus , 2014, Journal of Virology.
[58] B. Reinhard,et al. Interferon-Inducible Mechanism of Dendritic Cell-Mediated HIV-1 Dissemination Is Dependent on Siglec-1/CD169 , 2013, PLoS pathogens.
[59] A. Telenti,et al. Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides , 2012, PLoS biology.
[60] J. Martinez-Picado,et al. Sialyllactose in Viral Membrane Gangliosides Is a Novel Molecular Recognition Pattern for Mature Dendritic Cell Capture of HIV-1 , 2012, PLoS biology.
[61] A. Thomsen,et al. Sensing of RNA Viruses: a Review of Innate Immune Receptors Involved in Recognizing RNA Virus Invasion , 2012, Journal of Virology.
[62] R. Vanbever,et al. Analysis of sialoadhesin expression on mouse alveolar macrophages. , 2009, Immunology letters.
[63] S. Gummuluru,et al. Glycosphingolipid Composition of Human Immunodeficiency Virus Type 1 (HIV-1) Particles Is a Crucial Determinant for Dendritic Cell-Mediated HIV-1 trans-Infection , 2009, Journal of Virology.
[64] Scott A. Rifkin,et al. Imaging individual mRNA molecules using multiple singly labeled probes , 2008, Nature Methods.
[65] L. Pulliam,et al. Sialoadhesin Expressed on IFN-Induced Monocytes Binds HIV-1 and Enhances Infectivity , 2008, PloS one.
[66] Larissa B. Thackray,et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[67] A. Steinkasserer,et al. DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.
[68] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[69] R. Hubert,et al. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. , 2001, Cancer research.
[70] Jonathan M. Austyn,et al. Dendritic cells , 1998, Current opinion in hematology.
[71] P. Suter,et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. , 1996, American journal of respiratory and critical care medicine.
[72] E. Jones,et al. Characterization of the Sialic Acid-binding Site in Sialoadhesin by Site-directed Mutagenesis (*) , 1996, The Journal of Biological Chemistry.
[73] H. Saya,et al. Supplementary Figure Legends , 2012 .
[74] S. Akira,et al. TLR signaling. , 2006, Current topics in microbiology and immunology.
[75] J. Zwischenberger,et al. Severe respiratory failure. , 2001, The Annals of thoracic surgery.
[76] D. Jackson,et al. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. , 2001, Blood.
[77] P. Pothier. [Viral replication]. , 1997, La Revue du praticien.
[78] W. Spector. The macrophage in inflammation. , 1970, Series haematologica.
[79] in the protein , 2022 .